STTK
Shattuck Labs Inc

646
Mkt Cap
$123.15M
Volume
53,195.00
52W High
$2.71
52W Low
$0.6922
PE Ratio
-1.61
STTK Fundamentals
Price
$1.92
Prev Close
$1.95
Open
$1.92
50D MA
$1.86
Beta
1.69
Avg. Volume
1.42M
EPS (Annual)
-$1.49
P/B
1.64
Rev/Employee
$130,022.73
Loading...
Loading...
News
all
press releases
What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?
Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·22d ago
News Placeholder
More News
News Placeholder
Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Zacks·1mo ago
News Placeholder
Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock?
Shattuck Labs (STTK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2mo ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1y ago
News Placeholder
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK). Investors who...
Business Wire·1y ago
News Placeholder
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm STTK INVESTOR ALERT: Bronstein, Gewirtz and...
PR Newswire·1y ago
News Placeholder
GXO Logistics, Momentus, Shattuck Labs: 3 Stocks Retail Investors Are Most Bullish On Today
Potential sale talks, NASA contracts, and insider buybacks are sparking strong interest
Stocktwits·1y ago
News Placeholder
Shattuck Labs Stock Nosedives As Lead Cancer Therapy Fails: Retail Enthusiasm Evaporates
The Austin-based biotech firm also revealed plans to cut 40% of its workforce as part of a broader restructuring
Stocktwits·1y ago
News Placeholder
Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline
Shattuck Labs shifts focus to SL-325 after modest survival improvements in a Phase 1 trial for HR-MDS and TP53m AML. The company plans workforce reductions and expects cash reserves to last into...
Benzinga·1y ago

Latest STTK News

View

Advertisement|Remove ads.

Advertisement|Remove ads.